Market Research Logo

The World Market for Infectious Disease Diagnostic Tests


Attention: There is an updated edition available for this report.

The World Market for Infectious Disease Diagnostic Tests

World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening and subsegments within. POC and home testing markets for infectious disease are also provided. Sales and forecasts of infectious disease reagents are made through to 2019. Emerging products and markets are described; key players and strategies discussed and competitive trends are analyzed.

The market information provided in this report includes the following:

  • Infectious Disease Immunoassay Sales by Region
  • Infectious Disease Immunoassays Market Share
  • Infectious Disease Molecular Sales by Region
  • Infectious Disease Blood Screening Sales by Region
  • Infectious Disease Blood Screening Sales by Region
  • Infectious Disease Blood Screening Test Market Shares
  • ID/AST Test Market by Type
  • Infectious Disease ID/AST Sales by Region
  • ID/AST Leader Market Shares
  • Infectious Disease Immunoassays by Type
  • Laboratory Infectious Disease Immunoassays Sales by Disease
The disparity in infectious disease test market growth rates is immediately evident between industrialized, first-world countries with established healthcare systems in North America, Europe and Asia (Japan) and countries of the developing world (China, India, most of Latin America). The developed world is projected to be held to an under-4% aver annual growth rate in terms of infectious disease test sales through 2020. Countries such as China, India and in Latin America, on the other hand, remain in the process of implementing rapid testing as part of infectious disease screening and molecular assays for the diagnosis and treatment of infectious diseases. Even established infectious disease testing tools such as culture ID/AST can expect more robust rates of growth in the developing world as labs update their microbiology testing to automated platforms and increase capacity to handle increased patient volume. A global report, The World Market for Infectious Disease Tests offers geographic breakouts for market categories.

In addition, the report provides market shares for major testing categories and profiles companies. Trends in infectious diseases and in products are discussed. The information contained in this report has been assembled from primary and secondary data. Secondary data was collected from peer review journals and industry generated press releases. Primary research was conducted via telephone conversation with selected diagnostic marketers of in vitro diagnostics to assess the current market and trends in laboratory medicine.


  • Executive Summary
    • INTRODUCTION
    • THE GLOBALIZATION OF INFECTIOUS DISEASES
      • Table Infectious Diseases of Globalization and Their Drivers
    • MOUNTING THREAT OF MICROBIAL ANTIBIOTIC RESISTANCE
    • NEAR-PATIENT TESTING
    • THE GLOBAL MARKET FOR INFECTIOUS DISEASE TESTS
      • Table Worldwide Infectious Disease Test Market by Region/Country - North America, Western Europe (EU), Japan, China, India, Latin America, Rest of the World (ROW) (2015-2020) ($ millions)
      • ID/AST Market
        • Table Worldwide Infectious Disease Test Market by Test Segment – Laboratory Immunoassays, Rapid Professional POC Immunoassays, Rapid Home / OTC Immunoassays, ID/AST, Infectious Disease Molecular Assays, Blood Screening Immunoassays, Blood Screening Nucleic Acid Tests (2015-2020) ($ millions)
      • Infectious Disease Immunoassay Market
      • Blood Screening Assay Market
    • MAJOR CONCLUSIONS
  • Introduction to Infectious Diseases in Healthcare
    • INTRODUCTION TO THE EVOLVING WORLD OF INFECTIOUS DISEASE TESTING
      • Public Health Response
      • Funding Sources
    • LEADING DISEASE THREATS
    • LEADING INFETIOUS DISEASE TESTING TECHNOLOGIES
    • POINT OF VIEW
  • Trends in Clinical Infectious Diseases
    • BACKGROUND
    • THE GLOBALIZATION OF INFECTIOUS DISEASES
      • Globalization through Trade and Travel
      • Disease Burdens in Developing World
        • Table Infectious Diseases of Globalization and Their Drivers
    • VACCINES
      • Table Disease Preventable Vaccines in 2015
      • Table Preventive Vaccines in Development for Infectious Diseases (2015)
    • MOUNTING THREAT OF MICROBIAL ANTIBIOTIC RESISTANCE
      • Table Selected Advanced Antibiotic Resistance Tests
      • Table Selected Antibiotic Resistance Facts (CDC)
    • NEAR-PATIENT TESTING
      • Table Selected Advanced Near-Patient Infectious Disease Testing Platforms
      • Table Selected Microorganisms and Their Associated Diseases
    • NEW TECHNOLOGY PLATFORMS IN INFECTIOUS DISEASE TESTING
      • Real-Time PCR
      • Alternative Nucleic Acid Amplification Methods
        • Table Selected Isothermal Amplification Methods and Platform Examples
      • Sequencing
        • Table Selected Next Generation Sequencers for Infectious Disease Applications
        • Table Selected Infectious Disease Sequencing Innovations
      • Mass Spectrometry
        • Table Selected Mass Spectrometry Microbiology Platforms
      • Flow Cytometry
        • Table Selected Flow Cytometry Infectious Disease Applications
    • CONCLUSIONS
  • Overview of the Infectious Disease Test Market
    • BACKGROUND
    • THE WORLD MARKET FOR INFECTIOUS DISEASE TESTS
      • Table Worldwide Infectious Disease Test Market by Region/Country – North America, Western Europe (EU), Japan, China, India, Latin America, Rest of the World (ROW) (2015-2020) ($ millions)
    • INFECTIOUS DISEASE TEST MARKETS -ID/AST, IMMUNOASSAYS, MOLECULAR ASSAYS
      • Table Worldwide Infectious Disease Test Market by Test Segment – Laboratory Immunoassays, Rapid Professional POC Immunoassays, Rapid Home / OTC Immunoassays, ID/AST, Infectious Disease Molecular Assays, Blood Screening Immunoassays, Blood Screening Nucleic Acid Tests (2015-2020) ($ millions)
    • MAJOR COMPETITORS IN THE GLOBAL INFECTIOUS DISEASE TEST MARKET
      • Table Global Infectious Disease Test Market Shares - Abbott Diagnostics, Alere, Beckman Coulter, BD, bioMérieux, Bio-Rad Labs, Cepheid, DiaSorin, Grifols, Hologic, Meridian Bioscience, Ortho-Clinical Diagnostics, Quidel, Roche Diagnostics, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Others (%)
    • MARKET-LEADING INFECTIOUS DISEASES
      • Table Worldwide Infectious Disease Test Market by Major Diseases - HAI / AMR, Hepatitis, HIV, Respiratory, STDs / Women's Health, Other Infectious Diseases (2015) ($ millions)
  • The Market for Microbiology ID/AST Testing
    • BACKGROUND
      • Table Microbiology Sample/Specimen Types Ranked by Average Volume
    • LIQUID MICROBIOLOGY AND ID/AST AUTOMATION
    • MARKET ANALYSIS
      • Table Worldwide ID/AST Sales by Segment - Panels and Reagents, Blood Culture, Chromogenic Media, Rapid Micro (2015-2020) ($ millions)
      • Table Worldwide ID/AST Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020) ($ millions)
      • Table ID/AST Leader Market Shares - BD, Beckman Coulter, bioMérieux, Thermo Fisher Scientific, Others
      • Microbial Identification and Antimicrobial Susceptibility Systems
        • Table Selected ID/AST System Innovations
      • Chromogenic Media
        • Table Selected Chromogenic Media Innovations and Launches
      • Blood Culture
      • Vendor Developments in Blood Culture ID Testing
        • Table Selected Blood Culture Innovations and Launches
      • Rapid Tests
    • MARKET OUTLOOK FOR ID/AST TESTING
  • The Market for Immunoassays
    • BACKGROUND
    • SEPSIS SEROLOGY
      • Table Selected Sepsis Serology Innovations
      • Table Worldwide Infectious Disease Immunoassay Sales by Segment - Lab-Based, Rapid / POC (2015-2020) ($ millions)
      • Table Worldwide Infectious Disease Immunoassay Sales by Region – North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020) ($ millions)
      • Table Infectious Disease Immunoassay Leader Market Shares – Abbott Diagnostics, Alere, Beckman Coulter, bioMérieux, Bio-Rad Laboratories, DiaSorin, Meridian Bioscience, Ortho-Clinical Diagnostics, Quidel, Roche Diagnostics, Siemens Healthcare Diagnostics, Trinity Biotech, Others
      • Table Laboratory Infectious Disease Immunoassays Sales by Disease or Pathogen - Hepatitis, HIV, Mycology, Parasitology, Respiratory, Sepsis, Sexually Transmitted Diseases (STDs), ToRCH, Others (2015) ($ millions)
      • Table Selected Laboratory Infectious Disease Immunoassay Innovations
      • Table CLIA-Waived Infectious Disease Tests and Analytes
      • Table Rapid Infectious Disease Immunoassays Sales by Disease or Pathogen - C. difficile, E. coli, H. pylori, Hepatitis, HIV, Influenza, Malaria, Strep A, STDs, Others (2015) ($ millions)
      • Table Selected Rapid Infectious Disease Immunoassay Innovations
    • MARKET OUTLOOK FOR IMMUNOASSAY INFECTIOUS DISEASE TESTING
  • The Market for Molecular Assays
    • BACKGROUND
      • Table Selected Moderate and Waived Complexity Molecular Infectious Disease Testing Platforms
    • MARKET ANALYSIS
      • Table Worldwide Molecular Infectious Disease Assay Sales by Disease Area - CT/NG, HAIs, Hepatitis, HIV, HPV, Mycobacteria/TB, Respiratory, Others (2015-2020) ($ millions)
      • Table Molecular Infectious Disease Test Market Shares - Abbott Diagnostics, BD, bioMérieux, Cepheid, Hologic, QIAGEN, Roche Diagnostics, Siemens Healthcare Diagnostics, Others
    • CT/NG, HPV and Sexual Health / Women's Health
      • Table Selected Molecular Sexual Health and Women's Health Test Introductions and Innovations
    • Healthcare-Acquired Infections (HAIs) / Antimicrobial Resistance (AMR)
      • Table Selected Molecular Healthcare-Acquired Infection (HAI) / Antimicrobial Resistance (AMR) Test Introductions and Innovations
      • Table Selected Molecular Hepatitis Test Introduction and Innovations
    • HIV
      • Table Selected Molecular HIV Test Introduction and Innovations
    • Respiratory
      • Table Selected Molecular Respiratory Infection Test Introduction and Innovations
    • MARKET OUTLOOK FOR MOLECULAR INFECTIOUS DISEASE TESTING
  • The Infectious Disease Blood Screening Market
    • MARKET ANALYSIS
      • Table Commonly Tested Pathogens in Blood Screening
      • Table Worldwide Infectious Disease Blood Screening Test Sales – Immunoassays and Nucleic Acid Tests (NATs) (2015-2020) ($ millions)
      • Table Worldwide Infectious Disease Blood Screening Test Market by Region/Country - North America, Western Europe (EU), Japan, China, India, Latin America, Rest of the World (ROW) (2015-2020) ($ millions)
      • Table Infectious Disease Blood Screening Test Market Shares - Abbott Diagnostics, DiaSorin, Grifols, Hologic, Ortho-Clinical Diagnostics, Roche Diagnostics, Others
    • Immunoassays
      • Table Selected Blood Screening Immunoassay Introductions and Innovations
    • Nucleic Acid Tests (NATs)
      • Table Selected Blood Screening Nucleic Acid Test Introductions and Innovations
  • Company Profiles
    • ABBOTT DIAGNOSTICS
      • Table Abbott Diagnostics Revenue (2011-2014)
    • ALERE
      • Table Alere Revenue (2011-2014)
    • BECKMAN COULTER (DANAHER)
      • Table Beckman Coulter Revenue (2011-2014)
    • BECTON, DICKINSON & CO. (BD)
      • Table Becton, Dickinson & Co. (BD) Revenue (FY 2011-2014)
    • BIOMÉRIEUX
      • Table bioMérieux Revenue (2011-2014)
    • BIO-RAD LABORATORIES
      • Table Bio-Rad Laboratories Revenue (2011-2014)
    • CEPHEID
      • Table Cepheid Revenue (2011-2014)
    • CHEMBIO DIAGNOSTIC SYSTEMS
      • Table Chembio Diagnostics Systems Revenue (2011-2014)
    • COPAN DIAGNOSTICS
    • DIASORIN
      • Table DiaSorin Revenue (2011-2014)
      • Molecular
      • Blood Banking
    • GRIFOLS
      • Table Grifols Revenue (2011-2014)
      • Blood Screening (Molecular PROCLEIX Tests)
    • HOLOGIC
      • Table Hologic Revenue (FY 2011-2014)
      • Molecular Cytology / Histology (HPV)
      • Other Molecular (STIs, HIV, HCV, TB, Respiratory)
      • Microbiology (AccuProbe Molecular Culture ID Tests)
      • Blood Screening (Molecular PROCLEIX Tests)
    • MERIDIAN BIOSCIENCE
      • Table Meridian Bioscience Revenue (2011-2014)
    • ORASURE TECHNOLOGIES
      • Table OraSure Technologies Revenue (2011-2014)
    • ORTHO-CLINICAL DIAGNOSTICS
      • Table Ortho-Clinical Diagnostics Revenue (2011-2014)
    • QIAGEN
      • Table QIAGEN Revenue (2011-2014)
      • Molecular Diagnostics
      • Immunoassays
    • QUIDEL CORPORATION
      • Table Quidel Corporation Revenue (2011-2014)
    • ROCHE DIAGNOSTICS
      • Table Roche Diagnostics Revenue (2011-2014)
    • SIEMENS HEALTHCARE DIAGNOSTICS
      • Table Siemens Healthcare Diagnostics Revenue (FY 2011-2014)
    • THERMO FISHER SCIENTIFIC
      • Table Thermo Fisher Scientific Revenue (2011-2014)
    • TRINITY BIOTECH
      • Table Trinity Biotech Revenue (2011-2014)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report